Iptacopan hydrochloride by Novartis for Granulomatosis with Polyangiitis (Wegener’s Granulomatosis): Likelihood of Approval

Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase II for Granulomatosis with Polyangiitis (Wegener’s Granulomatosis).

Mass General Brigham, Concert Health Collaborate to Expand Behavioral Health Services for Primary Care

by Syed Hamza Sohail 10/03/2023 Leave a Comment What You Should Know: Concert Health, a leading behavioral health medical group, today announced a collaboration with Mass

October 4, 2023

Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation – Pharmaceutical Technology

Bernie Sanders, an independent senator from Vermont, has released a report claiming that Novo Nordisk’s GLP-1 receptor drugs could bankrupt the US entire healthcare system.

May 17, 2024

Surgeon General Was Warned by His Mom to Avoid Politics, but He Jumped Into the Fray

The dated gold and silver trophies packed in the china cabinet of the childhood home of Vivek Murthy, MD, MBA, still boast the surgeon general’s

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.